These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38594755)

  • 21. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
    Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
    J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First report in Africa of two clinical isolates of Proteus mirabilis carrying Salmonella genomic island (SGI1) variants, SGI1-PmABB and SGI1-W.
    Soliman AM; Ahmed AM; Shimamoto T; El-Domany RA; Nariya H; Shimamoto T
    Infect Genet Evol; 2017 Jul; 51():132-137. PubMed ID: 28359833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of
    Decôme M; Cuq B; Fairbrother JH; Gatel L; Conversy B
    Can J Vet Res; 2020 Oct; 84(4):252-258. PubMed ID: 33012973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India.
    Bhattacharya D; Thamizhmani R; Bhattacharya H; Sayi DS; Muruganandam N; Roy S; Sugunan AP
    Microb Drug Resist; 2013 Dec; 19(6):457-62. PubMed ID: 23862639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic and molecular characterization of antimicrobial resistance in Proteus mirabilis isolates from dogs.
    Harada K; Niina A; Shimizu T; Mukai Y; Kuwajima K; Miyamoto T; Kataoka Y
    J Med Microbiol; 2014 Nov; 63(Pt 11):1561-1567. PubMed ID: 25187600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Characterization of
    Sung JY; Kim S; Kwon G; Koo SH
    J Microbiol Biotechnol; 2017 Nov; 27(11):2052-2059. PubMed ID: 29032652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First Detection of New Delhi Metallo-β-Lactamase-5-Producing Escherichia coli from Companion Animals in Korea.
    Hong JS; Song W; Park HM; Oh JY; Chae JC; Han JI; Jeong SH
    Microb Drug Resist; 2019 Apr; 25(3):344-349. PubMed ID: 30379599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza, Palestine.
    Chen L; Al Laham N; Chavda KD; Mediavilla JR; Jacobs MR; Bonomo RA; Kreiswirth BN
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4305-7. PubMed ID: 25896692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region.
    Siebor E; Neuwirth C
    J Antimicrob Chemother; 2011 Nov; 66(11):2513-20. PubMed ID: 21846670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and characteristics of multidrug-resistant Proteus mirabilis from broiler farms in Shandong Province, China.
    Li Z; Peng C; Zhang G; Shen Y; Zhang Y; Liu C; Liu M; Wang F
    Poult Sci; 2022 Apr; 101(4):101710. PubMed ID: 35134599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France.
    Siebor E; Neuwirth C
    J Antimicrob Chemother; 2013 Aug; 68(8):1750-6. PubMed ID: 23580563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracking the Emergence and Dissemination of a
    García-González N; Beamud B; Fuster B; Giner S; Domínguez MV; Sánchez A; Sevilla J; Coque TM; Gimeno C; González-Candelas F;
    Microbiol Spectr; 2023 Apr; 11(2):e0258522. PubMed ID: 36722967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.
    Girlich D; Bonnin RA; Bogaerts P; De Laveleye M; Huang DT; Dortet L; Glaser P; Glupczynski Y; Naas T
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese Hospital.
    Hu YY; Cai JC; Zhang R; Zhou HW; Sun Q; Chen GX
    Antimicrob Agents Chemother; 2012 May; 56(5):2278-82. PubMed ID: 22354308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial Susceptibility and Molecular Epidemiology of
    Lin MF; Liou ML; Kuo CH; Lin YY; Chen JY; Kuo HY
    Microb Drug Resist; 2019 Nov; 25(9):1338-1346. PubMed ID: 31295061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotypic characterization of a Proteus mirabilis strain harboring bla
    Sun L; He J; Shi X; Hu L; Yin Y; Yu Y; Hua X
    J Infect Public Health; 2023 Jul; 16(7):1033-1036. PubMed ID: 37182289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community.
    Potron A; Hocquet D; Triponney P; Plésiat P; Bertrand X; Valot B
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristic of resistance to beta-lactam antibiotics of nosocomial strains of Proteus mirabilis].
    Ivanov DV
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):75-8. PubMed ID: 19189465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations.
    Luzzaro F; Perilli M; Amicosante G; Lombardi G; Belloni R; Zollo A; Bianchi C; Toniolo A
    Int J Antimicrob Agents; 2001 Feb; 17(2):131-5. PubMed ID: 11165117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of antimicrobial resistance and virulence markers in chicken originated Proteus mirabilis isolates.
    Sarıçam İnce S; Akan M
    Acta Vet Hung; 2024 Apr; 72(1):11-20. PubMed ID: 38578700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.